These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21156098)

  • 41. The changing epidemiology of varicella incidence after implementation of the one-dose varicella vaccination policy.
    Lian IeB; Chien YZ; Hsu PS; Chao DY
    Vaccine; 2011 Feb; 29(7):1448-54. PubMed ID: 21185851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strong Additional Effect of a Second Varicella Vaccine Dose in Children in Germany, 2009-2014.
    Siedler A; Rieck T; Tolksdorf K
    J Pediatr; 2016 Jun; 173():202-206.e2. PubMed ID: 26995703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Varicella vaccine effectiveness during an outbreak in a partially vaccinated population in Spain.
    Arnedo-Pena A; Puig-Barberà J; Aznar-Orenga MA; Ballester-Albiol M; Pardo-Serrano F; Bellido-Blasco JB; Romeu-García MA
    Pediatr Infect Dis J; 2006 Sep; 25(9):774-8. PubMed ID: 16940832
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Varicella vaccine].
    Abarca Villaseca K
    Rev Chilena Infectol; 2006 Mar; 23(1):56-9. PubMed ID: 16462966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of the universal infant varicella immunization strategy on Canadian varicella-related hospitalization rates.
    Waye A; Jacobs P; Tan B
    Vaccine; 2013 Oct; 31(42):4744-8. PubMed ID: 23973325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The epidemiology of varicella disease in Germany after introduction of a vaccination recommendation : Analysis of mandatory and sentinel data between 2002 and 2014].
    Hecht J; Siedler A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Jan; 60(1):118-126. PubMed ID: 27878603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perspective on live varicella vaccine.
    Gershon AA; Katz SL
    J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Varicella among adults: data from an active surveillance project, 1995-2005.
    Marin M; Watson TL; Chaves SS; Civen R; Watson BM; Zhang JX; Perella D; Mascola L; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S94-S100. PubMed ID: 18419417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increasing evidence of immunity to varicella among children in Massachusetts, 1999-2003.
    Lopez AS; Lett SM; Yih WK; Northrup J; Jumaan AO; Seward JF
    Am J Prev Med; 2006 Mar; 30(3):232-6. PubMed ID: 16476639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evolution of varicella surveillance--selected states, 2000-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(32):609-12. PubMed ID: 22895384
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Impact of universal varicella vaccination in Germany: an epidemiological and economic analysis].
    Knuf M; Neiss A; Wutzler P
    Klin Padiatr; 2006; 218(4):203-12. PubMed ID: 16819701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Assessment of the potential impact in Italy of extensive varicella vaccination programs based on a mathematical model].
    Salmaso S; Tomba GS; Mandolini D; Esposito N
    Epidemiol Prev; 2003; 27(3):154-60. PubMed ID: 12958734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A review of varicella vaccine and Louisiana vaccination requirements.
    Buff AM; Welch FJ; Tapia RA
    J La State Med Soc; 2004; 156(1):50-5. PubMed ID: 15000215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Varicella vaccination update].
    Nürnberg W; Schneeweiss B
    J Dtsch Dermatol Ges; 2006 Jul; 4(7):540-3. PubMed ID: 16827911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Safety and efficacy of varicella vaccine in healthy children--one year follow-up].
    Jackowska T; Dziadek J; Wasilewski R; Wasik M
    Med Wieku Rozwoj; 2008; 12(2 Pt 2):653-9. PubMed ID: 19418940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel.
    Sheffer R; Segal D; Rahamani S; Dalal I; Linhart Y; Stein M; Shohat T; Somekh E
    Pediatr Infect Dis J; 2005 May; 24(5):434-7. PubMed ID: 15876943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia.
    Gao Z; Gidding HF; Wood JG; MacIntyre CR
    Epidemiol Infect; 2010 Apr; 138(4):457-68. PubMed ID: 19781116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Seroprevalence rate after one dose of varicella vaccine in infants.
    Kim SH; Lee HJ; Park SE; Oh SH; Lee SY; Choi EH
    J Infect; 2010 Jul; 61(1):66-72. PubMed ID: 20380851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simultaneous administration of varicella vaccine and other recommended childhood vaccines--United States, 1995-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1058-61. PubMed ID: 11808928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.